FRIDAY, May 8, 2026 (Health Day News) — Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for ...

Two years ago, Jennifer Kirtley looked down at the scale and saw 328 pounds. Today, she’s looking in the mirror at a size 6.

Novo reported 1.3 million prescriptions for its weight-loss pill, which is now available in the U.S., in the first quarter of ...

If you are among the 40% of people in the U.S. with obesity, one of the most powerful actions you can take for your health is working with your healthcare provider to treat it. Obesity is nothing to ...

Wegovy maker Novo Nordisk boosted by successful weight loss pill launch - The launch in January came amid a battle in the ...

Q. My son stopped taking Wegovy due to strength loss. His job requires physical power, and he noticed that he wasn’t able to do as much as usual. Shouldn’t doctors warn patients about this when they ...

Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in GLP-1 ...

A recent FDA approval means consumers now have two GLP-1 weight loss pills to choose from as an alternative to the traditional injections.

Americans' voracious appetite for GLP-1 weight loss drugs has the nation on pace to spend more than $1 trillion on ...

The state, which is Maine's largest employer, will require employees to do health monitoring to retain insurance coverage.

In this edition of The People’s Pharmacy, Joe and Teresa Graedon also hear from a reader whose husband found a solution for seborrheic dermatitis on his scalp.